Efficacy of individualized homoeopathy in treatment of primary dysmenorrhea in adolescents:a randomized, double blind, placebo-controlled trial. - NI

Central Council for Research in Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年12月19日

试验速览

暂无简介。

•1.Patients conformed to the diagnostic criterion of Primary Dysmenorrhoea according to the Primary Dysmenorrhea Consensus Guidelines and if they had experienced primary dysmenorrhoea for two or more months.
•2.Age between 13 to 19 years.
•3.Menstrual cycle(21 to 35) days.
•4.Pain on numeric rating scale (NRS) >4.
•5.Signed informed consent of the parent and assent of the children.

•1.Secondary dysmenorrhea caused by endometriosis, uterine myoma, endometrial polyps, pelvic inflammatory disease, or other gynecological problems confirmed by a gynecological, abdominal ultrasound examination.
•2.Females with irregular/infrequent menstrual cycles (outside of the typical range 21 to 35 day’s cycle)
•3.Patients with haemoglobin less than 7gm/dl.
•4.Patients complicated with severe diseases (e.g. cerebral, liver, kidney, systemic diseases, mental disorders)
•5.Received other alternative therapies such as massage, acupressure, herbal therapy in the previous one month.
•6.Those who have been treated with hormone drugs over the last 3 months.
•7.poor treatment compliance (e.g. unstable working and living situation, difficult follow-up).

发起方

Central Council for Research in Homoeopathy